-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Hepatitis C is a kind of viral hepatitis, and its symptoms are not obvious, but if the infection is not treated in time, it will most likely become a chronic infection, and then develop into cirrhosis or even liver cancer
.
Statistics show that in recent years, China has maintained an annual increase of about 200,000 cases, and there are currently about 10 million infected people
.
Faced with such a large group, it is very important to implement hepatitis C prevention and control measures and safeguard measures
.
It is understood that in this context, Jointown and Gale will cooperate strongly to promote the implementation of new domestic liver disease drugs and help the hepatitis C elimination plan
.
On September 25th, Jointown has signed a cooperation agreement with Gele Biotechnology (Hangzhou) Co.
, Ltd.
and Golde Pharmaceutical (Zhejiang) Co.
, Ltd.
, which are subsidiaries of Golly Pharmaceuticals
.
According to the content of the cooperation, starting from October 1, 2021, Jointown will be responsible for the two independent original research anti-hepatitis C innovative drugs Xinlilai (Lavidavir Hydrochloride Tablets) and Ganovo (Danoprevir Sodium).
Film) in 13 provinces in China
.
It is reported that Ganovo and Xinlilai are all oral anti-hepatitis C class 1 new drugs originally developed by Gale, and both have been approved by the State Food and Drug Administration for marketing
.
The full oral anti-hepatitis C treatment plan composed of these two new drugs has completed phase II/III clinical trials in China.
The test results show that after 12 weeks of treatment, the cure rate of this plan for patients with genotype 1 non-cirrhosis (SVR12) Up to 99%, and for patients with NS5A resistance mutations at baseline, 100% achieved SVR12
.
Public information shows that Golly Pharmaceuticals is a biotechnology company dedicated to solving unmet medical needs in the three major areas of anti-virus, cancer and fatty liver disease
.
At present, the company has three commercialized products, and the research areas involve non-alcoholic steatohepatitis, tumors, and viral diseases, among which viral diseases mainly include hepatitis B, hepatitis C and AIDS
.
Jiuzhou Tongze is a major pharmaceutical company in China.
It has completed the construction and operation of 31 large-scale provincial-level pharmaceutical logistics centers and 110 prefecture-level small and medium-sized pharmaceutical logistics centers.
The storage area of pharmaceuticals that meets GSP standards has reached 2.
57 million square meters.
There are 1,871 logistics vehicles, a cold storage area of 44,900 square meters (with a volume of more than 100,000 cubic meters), and more than 430 refrigerated vehicles.
In addition, a new "Kyushu Cloud Warehouse" intelligent logistics information system has been built, which has realized the company's logistics network, Platform operation and panoramic digital control
.
The industry pointed out that in recent years, as the approval of new drugs has accelerated, the speed of drug launches has accelerated.
However, for innovative drug companies, especially those in the development stage, their promotion may face challenges when new products are launched.
Therefore, cooperation with third parties has become numerous The choice of SMEs
.
According to the announcement, through this cooperation, Ganovo and Xinlilai can rely on Jointown's own GSP warehousing and logistics system covering the whole country and related digital logistics operation system, which will benefit the primary medical market faster and bring to the majority of hepatitis C patients in China.
Gospel
.
It is understood that in addition to Geli Pharmaceutical, Jointown has also cooperated with many large domestic pharmaceutical companies, and there is no shortage of centralized procurement and bid-winning pharmaceutical companies
.
For example, on November 25, 2019, Jointown announced that the company signed a "Strategic Cooperation Framework Agreement" with Zhejiang Huahai Pharmaceutical Sales Co.
, Ltd.
, a subsidiary of Huahai Pharmaceutical Holdings
.
Judging from the content of the agreement, Jointown is mainly to help Huahai Pharmaceutical to increase the sales of its standard product Irbesartan tablets outside the scope of the expansion of centralized procurement, and to guarantee the medical distribution guarantee of the provinces selected in the alliance's procurement
.
.
Statistics show that in recent years, China has maintained an annual increase of about 200,000 cases, and there are currently about 10 million infected people
.
Faced with such a large group, it is very important to implement hepatitis C prevention and control measures and safeguard measures
.
It is understood that in this context, Jointown and Gale will cooperate strongly to promote the implementation of new domestic liver disease drugs and help the hepatitis C elimination plan
.
On September 25th, Jointown has signed a cooperation agreement with Gele Biotechnology (Hangzhou) Co.
, Ltd.
and Golde Pharmaceutical (Zhejiang) Co.
, Ltd.
, which are subsidiaries of Golly Pharmaceuticals
.
According to the content of the cooperation, starting from October 1, 2021, Jointown will be responsible for the two independent original research anti-hepatitis C innovative drugs Xinlilai (Lavidavir Hydrochloride Tablets) and Ganovo (Danoprevir Sodium).
Film) in 13 provinces in China
.
It is reported that Ganovo and Xinlilai are all oral anti-hepatitis C class 1 new drugs originally developed by Gale, and both have been approved by the State Food and Drug Administration for marketing
.
The full oral anti-hepatitis C treatment plan composed of these two new drugs has completed phase II/III clinical trials in China.
The test results show that after 12 weeks of treatment, the cure rate of this plan for patients with genotype 1 non-cirrhosis (SVR12) Up to 99%, and for patients with NS5A resistance mutations at baseline, 100% achieved SVR12
.
Public information shows that Golly Pharmaceuticals is a biotechnology company dedicated to solving unmet medical needs in the three major areas of anti-virus, cancer and fatty liver disease
.
At present, the company has three commercialized products, and the research areas involve non-alcoholic steatohepatitis, tumors, and viral diseases, among which viral diseases mainly include hepatitis B, hepatitis C and AIDS
.
Jiuzhou Tongze is a major pharmaceutical company in China.
It has completed the construction and operation of 31 large-scale provincial-level pharmaceutical logistics centers and 110 prefecture-level small and medium-sized pharmaceutical logistics centers.
The storage area of pharmaceuticals that meets GSP standards has reached 2.
57 million square meters.
There are 1,871 logistics vehicles, a cold storage area of 44,900 square meters (with a volume of more than 100,000 cubic meters), and more than 430 refrigerated vehicles.
In addition, a new "Kyushu Cloud Warehouse" intelligent logistics information system has been built, which has realized the company's logistics network, Platform operation and panoramic digital control
.
The industry pointed out that in recent years, as the approval of new drugs has accelerated, the speed of drug launches has accelerated.
However, for innovative drug companies, especially those in the development stage, their promotion may face challenges when new products are launched.
Therefore, cooperation with third parties has become numerous The choice of SMEs
.
According to the announcement, through this cooperation, Ganovo and Xinlilai can rely on Jointown's own GSP warehousing and logistics system covering the whole country and related digital logistics operation system, which will benefit the primary medical market faster and bring to the majority of hepatitis C patients in China.
Gospel
.
It is understood that in addition to Geli Pharmaceutical, Jointown has also cooperated with many large domestic pharmaceutical companies, and there is no shortage of centralized procurement and bid-winning pharmaceutical companies
.
For example, on November 25, 2019, Jointown announced that the company signed a "Strategic Cooperation Framework Agreement" with Zhejiang Huahai Pharmaceutical Sales Co.
, Ltd.
, a subsidiary of Huahai Pharmaceutical Holdings
.
Judging from the content of the agreement, Jointown is mainly to help Huahai Pharmaceutical to increase the sales of its standard product Irbesartan tablets outside the scope of the expansion of centralized procurement, and to guarantee the medical distribution guarantee of the provinces selected in the alliance's procurement
.
